PTH and osteoporosis: As the only approved anabolic agent, intermittent PTH therapy has been demonstrated to have beneficial effects on increasing bone mass and diminishing bone fragility associated with osteoporosis resulting from aging, sex hormone deficiency, and glucocorticoids use [46].